USPTO serial 99768436
ON-CHIP DRUG DISCOVERY
Status 641Office Action
- Filing date
- Apr 16, 2026
- Status date
- Aug 26, 2026
- Registration date
- —
- Examiner
- AURAND, KYLE C
Need help with ON-CHIP DRUG DISCOVERY?
CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Deadline: November 26, 2026
Office Action issues
The USPTO examiner refused registration in Class 9 due to potential confusion with existing "ON-CHIP" registered marks and requested a disclaimer for the descriptive wording in your mark.
Owner
SPOC Proteomics Inc.
Scottsdale, AZ, US
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Medical laboratory research instruments for evaluating pharmaceuticals, such as antibodies; Plates, glass slides or chips having multi-well arrays that can be used in chemical analysis, biological analysis or patterning for scientific, laboratory or medical research use; Sensor chips for scientific use | ACTIVE | — |
| 042 | Drug discovery services; Pharmaceutical products development; Pharmaceutical research services; Pharmaceutical product evaluation; Pharmaceutical drug development services; Pharmaceutical research and development; Development of pharmaceutical preparations and medicines; Technical research in the field of pharmaceutical studies; Research and development services of new pharmaceutical products; Research and development in the pharmaceutical and biotechnology fields; Research and development services in the field of pharmaceutical preparations; Pharmaceutical research in the field of therapeutic discovery and development; Testing of pharmaceuticals; Laboratory research services relating to pharmaceuticals; Research on the subject of pharmaceuticals; Laboratory research in the field of pharmaceuticals; Development of pharmaceuticals for cell and gene therapies; Testing of pharmaceuticals for cell and gene therapies; Testing, inspection or research of pharmaceuticals, cosmetics or foodstuff; Providing medical research information in the field of pharmaceuticals; Providing scientific research information in the field of pharmaceuticals; Conducting early evaluations in the field of new pharmaceuticals; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Laboratory services for the production of pharmaceuticals in the nature of testing of pharmaceuticals, including antibody-based therapeutics; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development services in the field of antibodies; Medical research; Medical research services; Medical research laboratory services; Medical research in the field of oncology; Medical research in the field of infectious diseases; Medical research services in the field of cancer; Medical research in the field of rare diseases; Medical research laboratory services in the field of oncology; Research and development services in the field of medical preparations; Scientific research for medical purposes in the area of cancerous diseases; Providing information about medical research in the field of therapeutic discovery and development; Medical and scientific research in the field of cancer treatment and diagnosis; Technology research in the field of therapeutic discovery and development; Medical research in the field of therapeutic discovery and development; Research and development in the field of therapeutic discovery and development; Scientific research for medical purposes in the field of therapeutic discovery and development; Medical and scientific research in the field of therapeutic discovery and development; Medical and scientific research information in the field of therapeutic discovery and development; Laboratory services for biomanufacturing; Laboratory services for biomanufacturing of antibodies, peptides, and proteins for therapeutic evaluation; Biological research; Biological research and analysis; Biological research laboratory services; Biological research in the field of therapeutic discovery and development; Research in the field of synthetic biology; Biomedical research services; Biomedical research in the field of therapeutic discovery and development; Biotechnology research; Research and development in the field of biotechnology; Research and development services in the field of biotechnology; Biotechnology research in the field of therapeutic discovery and development | ACTIVE | — |
Prosecution history
| Date | Code | Event |
|---|---|---|
| Aug 26, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Aug 26, 2026 | GNRT | NON-FINAL ACTION E-MAILED |
| Aug 26, 2026 | CNRT | NON-FINAL ACTION WRITTEN |
| Aug 24, 2026 | DOCK | ASSIGNED TO EXAMINER |
| Aug 20, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Apr 16, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED |
| Apr 16, 2026 | NWAP | NEW APPLICATION ENTERED |